Health Care

How much Analyst Suggested? ImmunoGen, Inc. (NASDAQ:IMGN)

0 15

ImmunoGen, Inc. (NASDAQ:IMGN) closed its last session at $2.87 with the change of +3.99%. The market capitalization of the company is $250.63M with an average Volume of 1.97 million shares. The stock currently has its 52-Week High range of $16.59 and 52-week low range of $2.53. The stock traded total quantity of 1.23 million shares.

Currently ImmunoGen, Inc. (IMGN) captured an average recommendation of “ Hold ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “3″ Analysts”. “1” rated “Sell” for the company. “4” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $7.71 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $20.00 however minimum price target advised by analysts is $2.50. The Median price target for the stock is measured at $6.00.

Presently, Analysts decided consensus EPS estimate of $-0.37 for present quarter and one month ago projected EPS estimate was at $-0.37. If we take a look at back 3 month ago, consensus EPS estimate was $-0.42.

A current consensus EPS estimate for next quarter is at $-0.37 and 3 month ago EPS forecast was $-0.41. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.37.

For current fiscal year, most recent EPS estimate is set at $-1.61 based on Analyst consensus and three month ago consensus EPS opinions was at $-1.66. During period one month ago, consensus EPS forecast was decided at $-1.61.

A current consensus EPS projection for next fiscal year is observed at $-1.62 and one month ago consensus EPS forecast was at $-1.62. Take a look at back three month ago, consensus EPS estimate opinions was decided at $-1.51 by analysts.

One Month ago, the stock has gained consensus mean rating of Hold based on the analysis of brokerage analyst firms polled. 3 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 4 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 4 said a “Buy Rating” and 0 announced “Overweight Rating”. 5 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.